Epidemics control and logistics operations- A review
临床试验常用的英文缩写
专业术语缩略语英文全称中文全称ADE Adverse Drug Event 药物不良事件ADR Adverse Drug Reaction 药物不良反应AE Adverse Event 不良事件AI Assistant Investigator 助理研究者BMI Body Mass Index 体质指数CI Co-investigator 合作研究者COI Coordinating Investigator 协调研究者CRA Clinical Research Associate 临床监查员(临床监察员)CRC Clinical Research Coordinator 临床研究协调者CRF Case Report Form 病历报告表CRO Contract Research Organization 合同研究组织CSA Clinical Study Application 临床研究申请CTA Clinical Trial Application 临床试验申请CTX Clinical Trial Exemption 临床试验免责CTP Clinical Trial Protocol 临床试验方案CTR Clinical Trial Report 临床试验报告DSMB Data Safety and monitoring Board 数据安全及监控委员会EDC Electronic Data Capture 电子数据采集系统EDP Electronic Data Processing 电子数据处理系统FDA Food and Drug Administration 美国食品与药品管理局FR Final Report 总结报告GCP Good Clinical Practice 药物临床试验质量管理规范GLP Good Laboratory Practice 药物非临床试验质量管理规范GMP Good Manufacturing Practice 药品生产质量管理规范IB Investigator’s Brochure研究者手册IC Informed Consent 知情同意ICF Informed Consent Form 知情同意书ICH International Conference on Harmonization 国际协调会议IDM Independent Data Monitoring 独立数据监察IDMC Independent Data Monitoring Committee 独立数据监察委员会IEC Independent Ethics Committee 独立伦理委员会IND Investigational New Drug 新药临床研究IRB Institutional Review Board 机构审查委员会IVD In Vitro Diagnostic 体外诊断IVRS Interactive Voice Response System 互动语音应答系统MA Marketing Approval/Authorization 上市许可证MCA Medicines Control Agency 英国药品监督局MHW Ministry of Health and Welfare 日本卫生福利部NDA New Drug Application 新药申请NEC New Drug Entity 新化学实体NIH National Institutes of Health 国家卫生研究所(美国)PI Principal Investigator 主要研究者PL Product License 产品许可证PMA Pre-market Approval (Application) 上市前许可(申请)PSI Statisticians in the Pharmaceutical Industry 制药业统计学家协会QA Quality Assurance 质量保证QC Quality Control 质量控制RA Regulatory Authorities 监督管理部门SA Site Assessment 现场评估SAE Serious Adverse Event 严重不良事件SAP Statistical Analysis Plan 统计分析计划SAR Serious Adverse Reaction 严重不良反应SD Source Data/Document 原始数据/文件SD Subject Diary 受试者日记SFDA State Food and Drug Administration 国家食品药品监督管理局SDV Source Data Verification 原始数据核准SEL Subject Enrollment Log 受试者入选表SI Sub-investigator 助理研究者SI Sponsor-Investigator 申办研究者SIC Subject Identification Code 受试者识别代码SOP Standard Operating Procedure 标准操作规程SPL Study Personnel List 研究人员名单SSL Subject Screening Log 受试者筛选表T&R Test and Reference Product 受试和参比试剂UAE Unexpected Adverse Event 预料外不良事件WHO World Health Organization 世界卫生组织WHO-ICDRA WHO International Conference of Drug Regulatory Authorities WHO国际药品管理当局会议Active Control 阳性对照、活性对照Audit Report 稽查报告Auditor 稽查员Blank Control 空白对照Blinding/masking 盲法/设盲Case History 病历Clinical study 临床研究Clinical Trial 临床试验Clinical Trial Report 临床试验报告Compliance 依从性Coordinating Committee 协调委员会Cross-over Study 交叉研究Double Blinding 双盲Endpoint Criteria/measurement 终点指标Essential Documentation 必需文件Exclusion Criteria 排除标准Inclusion Criteria 入选表准Information Gathering 信息收集Initial Meeting 启动会议Inspection 检察/视察Institution Inspection 机构检察Investigational Product 试验药物Investigator 研究者Monitor 监查员(监察员)Monitoring 监查(监察)Monitoring Plan 监查计划(监察计划) Monitoring Report 监查报告(监察报告) Multi-center Trial 多中心试验Non-clinical Study 非临床研究Original Medical Record 原始医疗记录Outcome Assessment 结果评价Patient File 病人档案Patient History 病历Placebo 安慰剂Placebo Control 安慰剂对照Preclinical Study 临床前研究Protocol 试验方案Protocol Amendments 修正案Reference Product 参比制剂Sample Size 样本量、样本大小Seriousness 严重性Severity 严重程度Single Blinding 单盲Sponsor 申办者Study Audit 研究稽查Subject 受试者Subject Enrollment 受试者入选Subject Enrollment Log 受试者入选表Subject Identification Code List 受试者识别代码表Subject Recruitment 受试者招募Study Site 研究中心Subject Screening Log 受试者筛选表System Audit 系统稽查Test Product 受试制剂Trial Initial Meeting 试验启动会议Trial Master File 试验总档案Trial Objective 试验目的Triple Blinding 三盲Wash-out 洗脱Wash-out Period 洗脱期[文档可能无法思考全面,请浏览后下载,另外祝您生活愉快,工作顺利,万事如意!]。
疾病预防控制机构名词解释
疾病预防控制机构名词解释1. 流行病学(Epidemiology):研究疾病在人群中的发生、分布和控制的科学领域。
流行病学主要关注疾病的原因、传播方式、发生率以及影响因素,通过数据收集和分析来提供预防与控制策略。
2. 疾病预防(Disease prevention):通过采取各种措施,减少疾病的发生和传播。
疾病预防可包括个体层面的行为改变、免疫接种、环境改善以及社会干预等多种手段。
3. 疾病控制(Disease control):在已经发生的疾病中采取控制措施,减少病情的严重程度和传播范围。
疾病控制可以包括病例筛查、治疗、隔离、隔离、干预措施、教育和宣传等手段。
4. 公共卫生(Public health):关注维护和改善整个人群的健康状态的学科和实践领域。
公共卫生的目标是预防疾病、延长寿命、提高生活质量,并关注社会环境、生活方式和个体的健康习惯等各种影响健康的因素。
5. 疫苗(Vaccine):通过注射或口服给予人体的一种生物制品,包含可以使人体产生免疫力的抗原。
疫苗可以预防某些传染病的发生,通过激活人体的免疫系统来抵抗病原体,提高人群的免疫水平。
6. 传染病(Infectious disease):由病原体(如细菌、病毒、真菌、原虫等)引起的可以在人群中传播的疾病。
传染病通过接触、空气传播、食物或水传播等途径传播到健康人群,会导致不同程度的疾病和感染。
7. 预防接种(Immunization):通过给予人体疫苗来刺激免疫系统,使其产生对某种疾病的免疫力。
预防接种可以有效地预防传染病的发生和传播,保护个体免受疾病的侵害。
8. 接触者追踪(Contact tracing):在传染病爆发或疫情扩散时,通过跟踪、筛查和隔离与病例接触过的人群,以防止疾病的进一步传播。
接触者追踪可以控制潜在感染者的传染性,减少疫情的扩散。
9. 卫生教育(Health education):通过信息传递和知识普及,提高人们对健康问题的认知水平,影响和改变他们的行为,从而达到预防疾病、促进健康的目的。
疾控中心流行病学调查信息管理系统的开发和应用
互联网+应用nternet Application 疾控中心流行病学调查信息管理系统的开发和应用□李克东山东省济宁市疾病预防控制中心【摘要】目的:为了使流行病患者信息采集、发病与就诊、危险因素与暴露史、密切接触者情况、实验室检测、调查分析的全过程进行自动化管理,实现流行病学调查业务管理的自动化、信息化、规范化,我们开发和应用了流行病学调查信息管理系统。
方法:系统采用B/S结构,界面框架果用eclipse工具进行开发,模块应用程序采用java进行了系统开发。
结果:该系统的使用进一步提高了检测确诊能力,缩短了检测时间,扩大了筛查范围,做到了早发现、早治疗,少传染、少恐慌,最大限度降低传染风险,可以大大提高流行病学调查管理人员的工作效率,使流行病学调查业务的管理更加准确、全面、完美、规范。
结论:提高了工作效率,规范了工作程序,做到了流行病学调查信息系统化、程序化、科学化。
【关键词】流行病学调查信息管理系统Development and application of epidemiological investigation information management system of CDCLi Kedong(Center for Disease Control and prevention,Jining City,Shandong Province, 272000)[Abstract]objective:In order to make the whole process of information collection,disease onset and treatment,risk factors and exposure history,close contacts,laboratory testing,investigation and analysis of epidemic patients automatic management,and realize the automation,informatization and standardization of epidemiological investigation business management。
阿卡波糖与格列吡嗪对降低2_型糖尿病患者血糖的疗效对比
阿卡波糖与格列吡嗪对降低2型糖尿病患者血糖的疗效对比朱为国,梁鸣,贾强强江苏省连云港市灌云县人民医院药学部,江苏连云港222200[摘要]目的研究2型糖尿病患者采用阿卡波糖、格列吡嗪治疗的治疗效果和药理价值。
方法选取2022年1—12月于连云港市灌云县人民医院中就诊的2型糖尿病患者120例为研究对象,采用随机数表法分为两组,每组60例。
采用格列吡嗪治疗的为格列吡嗪组,采用阿卡波糖治疗的为阿卡波糖组,比较两组血糖水平、治疗效果、不良反应发生率。
结果阿卡波糖组的糖化血红蛋白、空腹血糖、餐后2 h血糖优于格列吡嗪组,差异有统计学意义(P<0.05)。
阿卡波糖组总有效率为96.67%高于格列吡嗪组的88.33%,差异有统计学意义(χ2=5.689,P<0.05)。
两组不良反应发生率比较,差异无统计学意义(P>0.05)。
结论将阿卡波糖用于2型糖尿病患者治疗中,可更好地稳定血糖,在用药安全性上亦满足了患者需求。
[关键词] 阿卡波糖;格列吡嗪;2型糖尿病;血糖;效果分析[中图分类号] R4 [文献标识码] A [文章编号] 1672-4062(2023)05(b)-0112-04 Comparsion of Acarbose and Glipizide in Reducing Blood Glucose in Pa⁃tients with Type 2 Diabetes MellitusZHU Weiguo, LIANG Ming, JIA QiangqiangDepartment of Pharmacy, Guanyun County People´s Hospital, Lianyungang, Jiangsu Province, 222200 China [Abstract] Objective To study the therapeutic effect and pharmacological value of acarbose and glipizide in patients with type 2 diabetes. Methods A total of 120 patients with type 2 diabetes who received medical treatment in Guanyun County People´s Hospital of Lianyungang City from January to December 2022 were selected as the research objects and divided into two groups with 60 patients in each group by random number table method. Glipizide group was treated with glipizide group, and acarbose group was treated with acarbose group. Blood glucose level, therapeutic effect and incidence of adverse reactions were compared between the two groups. Results The glycated hemoglobin, fasting blood glucose, and 2-hour postprandial blood glucose of the acarbose group were better than those of glipizide group, and the difference was statistically significant (P<0.05). The total effective rate of the acarbose group was 96.67%, which was higher than 88.33% of the glipizide group, and the difference was statistically significant (χ2= 5.689, P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion When acarbose is used in the treatment of type 2 diabetes mellitus, it can better stabi⁃lize blood glucose and other related test values, and also meet the needs of patients in terms of drug safety.[Key words] Acarbose; Glipizide; Type 2 diabetes mellitus; Blood glucose; Effect analysis在中老年人群中,2型糖尿病的发病率极高[1],临床症状非常典型,极易诱发肾病、视网膜病等多种并发症[2]。
比尔盖茨,下一次的疫情,我们还没有准备好(文字版)
The Next Outbreak? We’re Not ReadyBill GatesWhen I was a kid, the disaster we worried about most was a nuclear war. That’s why we had a barrel like this down in our basement, filled with cans of food and water. When the nuclear attack came, we were supposed to go downstairs, hunker down, and eat out of that barrel. Today, the greatest risk of global catastrophe doesn’t look like this. Instead, it looks like this. If anything kills over 10 million people in the next few decades, it’s most likely to be a highly infectious virus rather than a war. Not missiles, but microbes. Now, part of the reason for this is that we’ve invested a huge amount in nuclear deterrents, but we’ve actually invested very little in a system to stop an epidemic. We’re not ready for the next epidemic.Let’s look at Ebola. I’m sure all of you read about it in the newspaper, lots of tough challenges. I followed it carefully through the case analysis tools we use to track polio eradication. And as you look at what went on, the proble m wasn’t that there was a system that didn’t work well enough, the problem was that we didn’t have a system at all. In fact, there’s some pretty obvious key missing pieces. We didn’t have a group of epidemiologists ready to go, who would have gone, seen what the disease was, seen how far it had spread. The case reports came in on paper. It was very delayed before they were put online, and they were extremely inaccurate. We didn’t have a medical team ready to go. We didn’t have a way of preparing people. Now, Médecins Sans Frontières did a great job orchestrating volunteers. But even so, we were far slower than we should have been getting the thousands of workers into these countries. And a large epidemic would require us to have hundreds of thousands of workers. There was no one there to look at treatment approaches; no one to look at the diagnostics; no one to figure out what tools should be used. As an example, we could have taken the blood of survivors, processed it, and put that plasma back in people to protect them. But that was never tried. So there was a lot that was missing. And these things are really a global failure.The WHO is funded to monitor epidemics, but not to do these things I talked about. Now, in the movies, it’s quite different. There’s a group of handsome epidemiologists ready to go, they move in, they save the day, but that’s just pure Hollywood. The failure to prepare could allow the next epidemic to be dramatically more devastating than Ebola.Let’s look at the progression of Ebola ove r this year. About 10,000 people died, and nearly all were in the three West African countries. There’re three reasons why it didn’t spread more. The first is that there was a lot of heroic work by the health workers. They found the people and they prevented more infections. The second is the nature of the virus. Ebola does not spread through the air. And by the time you’re contagious, most people are so sick that they’re bedridden. Third, it didn’t get into many urban areas. And that was just luck. If it had gotten into a lot more urban areas, the case numbers would have been much larger.So next time, we might not be so lucky. You can have a virus where people feel well enough while they’re infectious that they get on a plane or they go to a market. The source of the virus could be a natural epidemic like Ebola, or it could be bioterrorism. And so there are things that would literally make things a thousand times worse.In fact, let’s look at a model of a virus spread through the air, like the Spanish Flu b ack in 1918. So here’s what would happen: It would spread throughout the world very, very quickly. And you can see there’s over 30 million people [that/who] died from that epidemic. So this is a serious problem. We should be concerned.But in fact, we can build a really good response system. We have the benefits of all the science and technology that we talk about here. We’ve got cell phones to get information from the public and get information out to them. We have satellite maps where we can see where peo ple are and where they’re moving. We have advances in biology that should dramatically change the turnaround time to look at a pathogen and be able to make drugs and vaccines that fit for that pathogen. So we can have tools, but those tools need to be put into an overall global health system. And we need preparedness.The best lessons, I think, on how to get prepared are again, what we do for war. For soldiers, we have full-time, waiting to go. We have reserves that can scale us up to large numbers. NATO has a mobile unit that can deploy very rapidly. NATO does a lot of war games to check, are people well-trained? Do they understand about fuel and logistics and the same radio frequencies? So they are absolutely ready to go.So those are the kinds of things we need to deal with an epidemic. What are the key pieces?First is we need strong health systems in poor countries. That’s where mothers can give birth safely, kids can get all their vaccines, but also where we’ll see the outbreak very early on. We need a medical reserve corps: lots of people who’ve got the training and background who are ready to go, with the expertise. And then we need to pair those medical people with the military, taking advantage of the military’s ability to move fast, do logistics and secure areas. We need to do simulations, germ games, not war games, so that we see where the holes are. The last time a germ game was done in the United States was back in 2001, and it didn’t go so well. So far, the score is germs: 1, people: 0.Finally, we need lots of advanced R&D in areas of vaccines and diagnostics. There are some big breakthroughs, like the Adeno-associated virus, that could work very, very quickly. Now I don’t have an exact budget for what this would cost, but I’m quite sure it’s ver y modest compared to the potential harm. The World Bank estimates that if we have a worldwide flu epidemic, global wealth will go down by over three trillion dollars and we’d have millions and millions of deaths.These investments offer significant benefits beyond just being ready for the epidemic. The primary healthcare, the R&D – those things would reduce global health equity and make the world more just as well as more safe. So I think this should absolutely be a priority.There’s no need to panic. We don’t have to hoard cans of spaghetti or go down into the basement. But we need to get going, because time is not on our side. In fact, if there’s one positive thing that can come out of the Ebola epidemic, it’s that it can serve as an early warning, a wake-up call, to get ready. If we start now, we can be ready for the next epidemic.Thank you.。
疫情防控五字五类药品的储备调配流程
疫情防控五字五类药品的储备调配流程英文版The Stockpiling and Allocation Process of Five Types of Medications for Epidemic Prevention and ControlAs the world continues to grapple with the pandemic, effective and timely measures are crucial in mitigating its spread. Among these measures, the strategic stockpiling and allocation of essential medications play a pivotal role. This article outlines the stockpiling and allocation process for the "Five Types of Medications" critical for epidemic prevention and control.Identification and Prioritization: The first step involves identifying the five categories of medications that are most essential for epidemic control: antiviral drugs, antibiotics, immunomodulators, respiratory support drugs, and analgesics/antirheumatics. These medications are prioritized based on their importance in treating and managing the symptoms of the virus.Assessment of Needs: A comprehensive assessment is conducted to determine the estimated demand for each medication, taking into account factors like the current spread of the virus, the number of affected individuals, and the availability of alternative treatments.Stockpiling: Based on the assessment, strategic stockpiles of the identified medications are established. This involves ensuring sufficient quantities are available to meet the estimated demand while also considering the shelf life and storage requirements of each medication.Monitoring and Adjustment: Regular monitoring of stock levels is conducted to ensure they remain sufficient. Adjustments are made to the stockpiles as needed, taking into account changes in the epidemic situation, supply chain issues, and other relevant factors.Allocation and Distribution: The final step involves the allocation and distribution of the medications to healthcare facilities and other relevant organizations. This process iscarefully managed to ensure that the medications are distributed equitably and efficiently, reaching those who need them most.In conclusion, the stockpiling and allocation process for the Five Types of Medications for Epidemic Prevention and Control is a crucial aspect of pandemic management. It requires careful planning, continuous monitoring, and timely adjustments to ensure that essential medications are available when needed, thus contributing to the effective control of the pandemic.中文版疫情防控五字五类药品的储备调配流程随着全球继续与疫情作斗争,有效和及时的措施对于减轻其传播至关重要。
个案管理在慢性阻塞性肺疾病患者延续护理中的效果评价
·全科医疗和社区护理·个案管理在慢性阻塞性肺疾病患者延续护理中的效果评价金玮清 方炳 张娟 姜文婕 赵晓华(上海市长宁区虹桥街道社区卫生服务中心,上海 200051)摘 要 目的:评价个案管理在慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)患者延续护理中的效果。
方法:选取2019年7月—2020年12月上海市长宁区虹桥街道社区卫生服务中心诊治的COPD患者100例,按照随机数字表方法分成对照组和观察组各50例。
对照组仅进行门诊医生随访和社区护士电话随访,观察组采取从健康宣教、专病管理、康复训练和营养评估四个方面的个案管理。
比较两组在进行6个月、1年、1年半的管理后,肺功能指标、生命质量评分、知信行评分的变化情况。
结果:观察组干预后1年、1年半时的第一秒用力呼气容积(forced expiratory volume in one second,FEV1)、第一秒用力呼气容积占用力肺活量比值(FEV1/Forced vital capcacity,FEV1/ FVC)和知信行水平评分均高于对照组(均P<0.05)。
观察组干预后6个月、1年、1年半时的生命质量评分均低于对照组(P<0.05)。
结论:个案管理在COPD患者延续护理中具有重要作用,能够显著改善患者肺功能指标,提升其生活质量水平,值得研究和推广。
关键词 慢性阻塞性肺疾病;个案管理;延续护理中图分类号:R47 文献标志码:A 文章编号:1006-1533(2022)04-0030-04Evaluation of the effect of case management in continuous care of patients withchronic obstructive pulmonary diseaseJIN Weiqing, FANG Bing, ZHANG Juan, JIANG Wenjie, ZHAO Xiaohua(Hongqiao Community Health Service Center of Changning District, Shanghai 200051, China) ABSTRACT Objective: To evaluate the effect of the case management in continuous care of patients with chronic obstructive pulmonary disease(COPD). Methods: A total of 100 COPD patients diagnosed and treated in Hongqiao Community Health Service Center, Changning District, Shanghai from July 2019 to December 2020 were selected and divided into a control group and an observation group with 50 patients in each group according to random number table method. The control group was only followed up by out-patient doctors and community nurses by telephone, while the observation group adopted case management from four aspects: health education, special disease management, rehabilitation training and nutrition assessment.After 6 months, 1 year and 1 and a half years of management, lung function indexes, quality of life scores and knowledge, attitude and practice(KAP) scores changes of the two groups were compared. Results: The forced expiratory volume in one second(FEV1), the ratio of FEV1 / forced vital capacity(FEV1/FVC) and the scores of KAP in the observation group at 6 months, 1 year and 1.5 years after intervention were higher than those in the control group(all P<0.05). The life quality score of the observation group was lower than that of the control group at 6 months, 1 year and 1 and a half after intervention(P<0.05).Conclusion: Case management plays an important role in the continuous care of COPD patients, can significantly improve the lung function indicators of patients, and improve their quality of life, which is worthy of research and promotion.KEY WORDS chronic obstructive pulmonary disease;case management;continuous care慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是一种以气道不完全可逆气流受限作基金项目:上海市长宁区科学技术委员会科研项目(CNKW2018Y27)通信作者:赵晓华。
幼儿园疫情防控工作方案
幼儿园疫情防控工作方案幼儿园疫情防控工作方案为了保障幼儿园师生的健康与安全,我们制定了以下疫情防控工作方案:1.给予1-6岁易感儿童传染病疫苗接种,并及时隔离治疗传染病人,要求家长领孩子回家隔离。
在室内加强通风、换气,采用消毒药液浸泡、清洗、暴晒等方法清洁玩具、生活用具,不允许XXX与患儿接触。
2.如果幼儿或教职工出现非典、禽流感、风疹、流脑、麻疹、流感等传染性疾病,应及时就医并向学校请假。
经医院诊断排除传染病后,才能回校上课、上班。
3.如果幼儿或教职工在校内出现传染病,应及时组建处理病情的领导小组,要求传染病者立即戴防护口罩、手套,到隔离室休息。
幼儿园安全管理人员或卫生保健老师应立即通知传染病医院,需转医院治疗的应立即转至传染病医院。
班主任应立即通知幼儿家长,由家长陪同去医院,如家长不能到园,则由班主任老师护送去医院(护送人员都要穿好防护服,戴口罩、手套)。
如果是本园教职工出现传染病,也要求戴防护口罩、手套,由医生初步检查后,如为传染病则立即转至市传染病医院并通知其家属,如家属不能到校,则由保健医护送去医院(护送人员都要穿好防护服,戴口罩、手套)。
4.在园内发现传染病的幼儿或教职工,应急小组领导应立即亲临现场指挥,在第一时间内利用幼儿园隔离室进行隔离观察,并由安全管理人员或卫生保健老师马上打“120”电话,送定点传染病医院诊治。
5.幼儿园对传染病病人所在班级教室或活动场所进行全面消毒,确保幼儿园环境的卫生与安全。
通过以上疫情防控工作方案,我们将确保幼儿园师生的健康与安全,为幼儿的健康成长提供有力保障。
为了有效防止疫情扩散,幼儿园需要采取一系列措施,包括对办公室和公共场所进行消毒,对与传染病人密切接触的学生和教职工进行隔离观察等。
同时,传染病人在医院接受治疗时,应禁止任何人前往探望。
如果在幼儿园发现有传染病人,应立即上报区教育局和区疾控中心,并对病人进行跟踪了解。
如果病情严重,需要请示上级部门决定是否停课,并采取一切有效措施,封锁疫点,进行消毒,并进行疫情调查。
欧盟批准Nycomed公司罗氟司特用于治疗慢性阻塞性肺疾病
个单 位 效 果 所 需 费 用越 低 。增 量 成 本 一效 果 比 ( C A )则 A /E
・
国外 药 讯 ・
欧 盟 批 准 Ny o e 公 司 cm d
罗 氟 司 特 用 于 治 疗 慢 , 阻 塞 , 肺 疾 病 陛 陛
4 8小 时 , B组 所 需 的 平 均 输 血 量 较 A 组 少 , 此 , 因 B组 治 疗
迪 , 子 江 制 药 有 限 公 司 ) B组 : 1 h静 脉 注 射 奥 美 拉 唑 扬 ; 每 2 钠 4 mg 洛 赛 克 , 0 ( 阿斯 利 康 制 药 有 限 公 司 ) 疗 程 为 5天 。 , 1 3疗 效 判 断 . 患 者 应 用 泮 托 拉 唑 钠 或 奥 美 拉 唑 钠 治 疗 后
性 ( > O 0 ) 具 有 可 比性 。 P .5,
代 表 一 个 方 案 成 本 一 效 果 与 另一 个 方 案 比较 所 得 结 果 , 最 以 低 成本 方 案 为 参 考 , 他 方 案 与 之 对 比 而 得 n / E 越 低 其 Cn
表 明增 加 1 效 果 单 位 所需 追 加 的 费 用 越 低 , 方 案 的实 际 个 该
A 组 不 良 反应 例 数 为 3例 。 要 为 发 热 、 晕 、 主 头 乏力 。B组 不
良反 应 例 数 为 2例 , 要 为 发热 、 力 。 两 组 治 疗 效 果 详 见 主 乏
表 1 。
表 1 两 组 治 疗 效 果 比较
济学研究在优化治疗方案 、 导合理用药 、 低治疗成本 、 指 降 合
方案更 为经济 、 理 。 合
高密度脂蛋白胆固醇与年龄相关性黄斑变性关联关系的孟德尔随机化研究_秦雪英
·论著·高密度脂蛋白胆固醇与年龄相关性黄斑变性关联关系的孟德尔随机化研究秦雪英1,田君1,方凯1,李娟2,于文贞3,侯婧3,陈大方1,黎晓新3△,胡永华1△(1.北京大学公共卫生学院流行病与卫生统计学系,北京100191;2.北京市疾病预防控制中心,北京100013;3.北京大学人民医院眼科,北京100044)[摘要]目的:探索血清高密度脂蛋白胆固醇(high-density lipoprotein cholesterol ,HDL-C )与年龄相关性黄斑变性(age-related macular degeneration ,AMD )的关联关系。
方法:在全国多所医院收集AMD 病例和对照样本,通过眼科检查确诊AMD ,收集的资料包括研究对象的一般人口学特征、行为因素、体格检查、抽血测定血清HDL-C 水平等,还对血标本进行遗传易感性检测。
采用孟德尔随机化方法,以肝酯酶基因(hepatic lipase gene ,LIPC )的功能性突变位点rs10468017作为工具变量,分析HDL-C 与AMD 的关系。
结果:研究共纳入545名AMD 患者和480名对照。
LIPC 不同基因型之间,研究对象的年龄、性别、居住地、吸烟、饮酒、饮茶、体质指数的分布差异均无统计学意义(P >0.05),满足作为工具变量的条件。
应用传统的回归模型得到,血清HDL-C 与AMD 关联的OR 值为2.00(95%CI :1.41 2.86),孟德尔随机化方法中得到的OR 值为7.15(95%CI :0.80 64.13)。
结论:与既往研究结果不同,本研究采用孟德尔随机化方法未发现观察性研究中血清HDL-C 水平升高与AMD 呈正相关的结果。
[关键词]黄斑变性;胆固醇,高密度脂蛋白;脂肪酶;肝;孟德尔随机化[中图分类号]R774.5[文献标志码]A[文章编号]1671-167X (2012)03-0407-05doi :10.3969/j.issn.1671-167X.2012.03.016Mendelian randomization study of the relationship between high-density lipoproteincholesterol and age-related macular degenerationQIN Xue-ying 1,TIAN Jun 1,FANG Kai 1,LI Juan 2,YU Wen-zhen 3,HOU Jing 3,CHEN Da-fang 1,LI Xiao-xin 3△,HUYong-hua 1△(1.Department of Epidemiology and Biostatistics ,Peking University School of Public Health ,Beijing 100191,China ;2.Beijing Center for Disease Control and Prevention ,Beijing 100013,China ;3.Department of Ophthalmologic ,Peking Uni-versity People ’s Hospital ,Beijing 100044,China )ABSTRACTObjective :To explore genetic variants robustly associated with high-density lipoprotein cho-lesterol (HDL-C )by Mendelian randomization analysis and to examine its causal association with age-re-lated macular degeneration (AMD ).Methods :AMD cases and controls were selected from several hos-pitals nationwide.Their AMD was diagnosed by eye examination ,serum HDL-C levels were examined by blood tests ,and other informations were also collected including demographic characteristics ,high risk behaviors and so on.The genetic loci hepatic lipase gene (LIPC )rs10468017was used as instrumental variables for HDL-C.Results :The study population contained hospital-based 545AMD patients and 480controls.The LIPC genotypes were unrelated to all potentially confounding factors measured in this study.In conventional multivariable analyses ,the HDL-C level was positively associated with AMD.The oddsratio was 2.00(95%CI :1.41-2.86).Instrumental variable analyses (Mendelian randomization ap-proach )showed an increasing odds ratio of HDL-C and AMD ,which was 7.15(95%CI :0.80-64.13).Conclusion :Being different with previous observational analysis ,this study did not support the status of increasing serum HDL-C level as a risk factor for AMD by Mendelian randomization analysis.KEY WORDS Macular degeneration ;Cholesterol ,HDL ;Lipase ;Livers ;Mendelian randomization基金项目:“十一五”国家科技支撑计划项目(2006BAI02B05)和教育部博士点新教师基金(20110001120032)资助Supported by the NationalScience &Technology Pillar Program During the 11th Five-Year Plan (2006BAI02B05)and Doctoral Fund of Ministry of Education of China(20110001120032)△Corresponding author ’s e-mail ,yhhu@bjmu.edu.cn ;dr_lixiaoxin@163.com 网络出版时间:2012-5-2814ʒ26ʒ03网络出版地址:http ://www.cnki.net /kcms /detail /11.4691.R.20120528.1426.005.html 年龄相关性黄斑变性(age-related macular de-generation ,AMD )又称老年性黄斑变性,是一种随年龄增加而发病率上升并导致双眼中心视力进行性下降的疾病。
浅谈疾病预防控制专业人员具备的能力与素质
中国卫生产业CHINA HEALTHINDUSTRY疾病预防控制工作是我国基本医疗卫生保障体系的重要组成部分[1]。
随着医药卫生体制改革不断深入推进,疾病预防控制工作越来越繁重,群众对疾病预防控制服务均等化的期望也越来越高[2],对疾病预防控制专业人员的专业技能和管理水平也提出了更高的要求。
但目前,基层疾病预防控制机构专业人员的学历结构、知识结构、专业结构、专业技能、管理水平、服务理念等诸多方面与群众期望和要求还有相当大的差距。
面对新形势、新任务、新挑战,当务之急要切实加强疾病预防控制专业人员教育、培训、培养与管理,努力提高其专业技术水平和管理能力等综合素质,才能保证各项疾病预防控制职责任务落实到位,努力满足群众不断增长的健康服务需求,这样才能适应事业发展需要,才能体现应有的社会价值,才能提高应有的社会地位,彰显社会存在的职业自豪。
1疾病预防控制专业人员面临的任务与挑战传统的粗放式人才管理方式越来越不适应日益繁重和规范化、精细化、信息化管理要求越来越高的疾病预防控制事业发展[3]。
单一的生物医学服务模式已越来越不能满足疾病DOI:10.16659/ki.1672-5654.2017.01.043浅谈疾病预防控制专业人员具备的能力与素质柯华,柴玲湖北省十堰市郧阳区疾病预防控制中心,湖北十堰442500[摘要]疾病预防控制机构是政府实施疾病预防控制与公共卫生技术管理和服务的公益事业单位。
其专业人员素质是完成机构主要职责任务的重要保证。
随着医药卫生体制改革不断深入推进,疾病预防控制工作越来越繁重,群众对疾病预防控制服务均等化的期望也越来越高。
因此,疾病预防控制专业人员应树立五大意识、增强五种能力,具备良好的管理水平和专业技能等综合素质,保证机构主要职责任务落实到位,满足群众不断增长的健康服务需求。
[关键词]疾病预防控制人员;综合素质;专业技能[中图分类号]R197.1[文献标识码]A[文章编号]1672-5654(2017)01(a)-0043-03Analysis of Ability and Quality of Disease Prevention and Control Profes⁃sional StaffKE Hua,CHAI LingDisease Prevention and Control Center,Shiyan,Hubei Province,442500China[Abstract]The disease prevention and control institutions are the public welfare institutions of the implementation of dis⁃ease prevention and control and public health technical management and service by governments,and the quality of profes⁃sional staff is an important guarantee of completing the major duty of institutions,with the continuous promotion and medi⁃cal health system,the disease prevention and control work becomes heavier and heavier and people’s expectation for the even disease prevention and control service becomes higher and higher,therefore,the disease prevention and control profes⁃sional staff should establish five awareness and enhance five abilities,own the good management level and professionalskill,ensure the implementation of major duties of institutions and meet the ever-increasing health service demands.[Key words]Disease prevention and control staff;Comprehensive quality;Professional skill[作者简介]柯华(1973.7-),男,湖北十堰人,本科,副主任医师,主要从事疾病预防控制业务管理工作。
大型综合医院急诊科应对新型冠状病毒肺炎疫情经验探索
417 V ol.40 No.4 Apr. 2020上海交通大学学报(医学版)JOURNAL OF SHANGHAI JIAO TONG UNIVERSITY (MEDICAL SCIENCE)新型冠状病毒防控专栏目前,全世界正经历着一场重大的新型冠状病毒肺炎(coronavirus disease 2019,COVID-19)疫情。
截至2020年3月18日0时,全国确诊病例达到81 116例,死亡3 231例[1]。
大型综合性医院急诊科作为医院应对本次疫情的最前沿场所,面临着如何处理好疫情防控和普通急诊患者救治之间矛盾的巨大挑战,上海交通大学医学院附属瑞金医院急诊科经过2个月左右的实践探索,总结了一系列措施和改进方案。
1疫情防控期间发热急诊的应对措施急诊科自2020年1月19日8:00至3月17日24:00共接诊发热患者3 098例,共启动院内/区级专家会诊171次,发现“疑似”患者47例,确诊9例,排除38例(图1)。
确诊患者中,男6例,女3例,其中4例存在武汉相关接触史,4例有聚集性发病情况,1例为境外输入性。
在应对本次疫情过程中,初步实现了医务人员“零感染”,患者“零漏诊”,积累了一定经验,取得了满意的成效。
大型综合医院急诊科应对新型冠状病毒肺炎疫情经验探索杨之涛,高卫益,梁 婧,景 峰,毛恩强,陈尔真上海交通大学医学院附属瑞金医院急诊科,上海 200025[摘要] 2019年12月至今,新型冠状病毒肺炎(coronavirus disease 2019,COVID-19)疫情已经发展至全球。
通过一系列防控措施,我国疫情已经得到基本控制;但其他国家和地区发病人数、死亡人数仍在快速上升。
应对如此重大的疫情,医院的应急管理体系受到了严峻考验,尤其是医院的急诊科承担了发热患者筛查诊断及普通患者的急诊急救。
上海交通大学医学院附属瑞金医院经过2个月左右的实践探索,在应急管理制度完善、平战结合机制建立、医疗资源重组、物资调配保障、信息系统优化等方面总结了一些经验,实现医务人员“零感染”,COVID-19患者“零漏诊”和“零交叉感染”的目标。
中国临床微生物实验室应对重大传染病疫情能力建设指导原则
·18·Chinese Hospitals,Aug.2020,Vol.24,No.8中国临床微生物实验室应对重大传染病疫情能力建设指导原则基金项目:国家科技重大专项“病原细菌与突发急性真菌感染高通量快速检测与应急筛检技术研究”(2018ZX10712001);中国科学院临床研究医院“新型冠状病毒感染应急科技攻关专项项目”(YD9110002001);中国医学科学院医学与健康科技创新工程“重要新发突发传染病生物安全基础与防控技术研究”(2016-I2M-1-014)①中国医院协会临床微生物实验室专业委员会,100730 北京市东城区帅府园1号■ 中国医院协会临床微生物实验室专业委员会①【摘 要】近年来,重大传染病疫情在全球范围内时有发生,临床微生物实验室在重大传染病的诊断、治疗和防控工作中具有至关重要的作用。
本指导原则结合当前新型冠状病毒肺炎(COVID-19)疫情及中国临床微生物实验室现状,针对临床微生物实验室应对重大传染病疫情应具备的综合能力,从实验室建筑布局、实验室管理及生物安全、技术平台建设、人员能力建设、质量保证和临床研究能力提升等方面,提供了指导意见。
以实现平战结合,在加强临床微生物实验室能力建设的基础上,满足重大传染疫情突发和常态化检验需求。
【关键词】重大传染病 突发疫情 临床微生物 实验室检测中图分类号 R372 文献标识码 A DOI 10.19660/j.issn.1671-0592.2020.08.06Guideline of capacity-building for dealing with major infectious diseases epidemic in Chinese clinical microbiology laboratories/ Sub-committee of Clinical Microbiology Laboratory, China Hospital Association // Chinese Hospitals. -2020,24(8):18-22【Abstract】Major infectious diseases epidemics outbroke all over the world in recent decades. Clinical laboratories play an important role in the diagnosis, therapy and control of the major infectious diseases. Based on the current situation of coronavirus disease 2019 (COVID-19) epidemic and the status of Chinese clinical microbiology laboratories, this guideline offers recommendations on comprehensive capacity-building for dealing with major infectious diseases epidemic, including laboratory building layout, laboratory management, biosafety, technological platforms building, stuff capacity-building, quality assurance and clinical study capacity improvement, to satisfy both emergency and routine test needs of major infectious diseases epidemic.【Key words】major infectious diseases, epidemic outbreak, clinical microbiology, laboratory detectionAuthor's address:Sub-committee of Clinical Microbiology Laboratory, China Hospital Association , No.1,Shuaifuyuan, Dongcheng District, Beijing, 100730, PRC重大传染病疫情是指某种传染病在短时间内发生、波及范围广泛,出现大量的病人或死亡病例,其发病率远远超过常年发病率水平的情况。
英文版 预防医学专业介绍
预防医学英文版专业介绍Preventive medicine is based on "environment - the crowd - health" model to the crowd as the research object in order to prevent the main guiding ideology and use of modern medical knowledge and methods of environment on the health effects of the law of human disease occurred in the formulation of preventive measures to achieve health promotion, prevention of disability and mortality for the purpose of a science. Preventive medicine features include: work targeting individuals and groups, the focus is healthy and asymptomatic patients, countermeasures are more positive preventive effect, more people health benefits, research methods, focus more on micro-and macro-combination of research priorities the environment and the relationship between population health.Preventive medicine and clinical difference is that she took the crowd for the object, rather than confined to the individual as the target. Medical trend is one of the development of medicine from the individual to a group of medicine, many of today's real resolve medical problems, it is impossible to leave the group and group medical methods. The task of preventive medicine requires it must be able to face the future of medicine, from a strategic height to consider human diseases and health problems.The application of modern medicine and other disciplines of scienceand technology means to study human health and the relationship between environmental factors to develop disease control strategies and measures to achieve control of disease, to protect people's health and prolong human life purposes. With the medical model of development, the profession increasingly shown its importance in medical science.The professional training in preventive medicine research and experimental work and the work has a certain level of health management of knowledge and foreign language health physician. Students to master the general theory of knowledge and skills in clinical medicine, based on the systematic grasp of the profession can be the basis of theory, basic knowledge and basic skills, able to use what they have learned the knowledge, skills, engaged in practical work and scientific research.Business training goal: This professional development with the basic theoretical knowledge of preventive medicine and health detection technology in health and disease prevention, environmental health or food health monitoring in preventive medicine institutions such as the work of senior medical professionals.。
疫情防疫常态化对旅游业的影响研究
1引言旅游业作为第三产业,对地区经济与文化发展有巨大的推动作用,正在成为国民经济增长的重要引擎。
近年来,旅游业以及相关产业发展迅速,中国旅游研究院发布的《2019年旅游市场基本情况》中显示,在2019年,旅游经济的增长速度高于GDP 增长,国内旅游人数达到了60.06亿人次;入出境旅游总人数3.0亿人次;旅游业对GDP 的综合贡献为10.94万亿元,占GDP 总量的11.05%。
与2015年相比,2019年中国旅游总收入由4.13万亿元增长到了6.63万亿元。
旅游业不仅可以推动地区经济发展,对就业也有重大影响,在2019年年末疫情爆发之前,根据中国文旅部统计数据显示,直接从事旅游业的人数就高达2825万,直接与间接就业之和为7987万人,占全国就业总人口的10.31%[1]。
疫情爆发前,我国旅游主体主要由城镇与农村居民组成,其中城镇居民由于收入水平较高,外出旅游已经较为普及,其人均出游率和人均旅游消费都大幅高于农村居民,例如,2018年农村居民出游人数已经高达14.2亿人次,花费0.87万亿元,虽然无论是出游人数、花费还是增长速度,农村居民都不及城镇居民但也在稳定增长。
2020年初,疫情突然爆发,人们的出行受到限制,大部分旅游景点关门,本该是旅游小高峰的春节假期却四下无人,旅游人数与旅游收入骤减,对我国的旅游行业造成了一定的打击。
2疫情防疫常态化对旅游业的影响在过去一年中,我国逐渐控制住疫情并进入了疫情防控常态化,尽管旅游业得到了一定恢复,然而小范围感染偶尔发生且疫情在其他众多国家依旧较为严重。
根据科研表明,病毒可能与人类长期共存,因此,如何以“疫情防控常态化”作为约束条件来规划行业未来的长期发展与走向是旅游业面临的一大问题。
2.1居民出行规划与模式改变,然旅游意愿不改防疫常态化下,人们的旅游规划呈现出“短期、短程”的特点。
虽然我国疫情稳定,但零星地区仍然不时会有小规模疫情爆发,这使得部分游客的旅游意向与旅游规划受到了不同程度的影响。
特蕾莎修女英文介绍
On 10 September 1946, Teresa experienced what she later described as "the call within the call" while travelling by train to the Loreto convent in Darjeeling from Calcutta for her annual retreat. "I was to leave the convent and help the poor while living among them. It was an order. To fail would have been to break the faith."[23] As one author later noted, "Though no one knew it at the time, Sister Teresa had just become Mother Teresa".[24]She began her missionary work with the poor in 1948, replacing her traditional Loreto habit with a simple white cotton sari decorated with a blue border. Mother Teresa adopted Indian citizenship, spent a few months in Patna to receive a basic medical training in the Holy Family Hospital and then ventured out into the slums.[25][26] Initially she started a school in Motijhil (Calcutta); soon she started tending to the needs of the destitute and starving.[27] In the beginning of 1949 she was joined in her effort by a group of young women and laid the foundations to create a new religious community helping the "poorest among the poor".Her efforts quickly caught the attention of Indian officials, including the prime minister, who expressed his appreciation.[28]Teresa wrote in her diary that her first year was fraught with difficulties. She had no income and had to resort to begging for food and supplies. Teresa experienced doubt, loneliness and the temptation to return to the comfort of convent life during these early months. She wrote in her diary:Our Lord wants me to be a free nun covered with the poverty of the cross. Today I learned a good lesson. The poverty of the poor must be so hard for them. While looking for a home I walked and walked till my arms and legs ached. I thought how much they must ache in body and soul, looking for a home, food and health. Then the comfort of Loreto [her former order] came to tempt me. 'You have only to say the word and all that will be yours again,' the Tempter kept on saying ... Of free choice, my God, and out of love for you, I desire to remain and do whatever be your Holy will in my regard. I did not let a single tear come.[29]Teresa received Vatican permission on 7 October 1950 to start the diocesan congregation that would become the Missionaries of Charity.[30] Its mission was to care for, in her own words, "the hungry, the naked, the homeless, the crippled, the blind, the lepers, all thos e people who feel unwanted, unloved, uncared for throughout society, people that have become a burden to the society and are shunned by everyone."It began as a small order with 13 members in Calcutta; by 1997 it had grown to more than4,000 sisters running orphanages, AIDS hospices and charity centres worldwide, and caring for refugees, the blind, disabled, aged, alcoholics, the poor and homeless, and victims of floods, epidemics, and famine.[31]2005 Image of Mother Teresa's Home for the Dying, Nirmal Hriday, in Kolkata.In 1952 Mother Teresa opened the first Home for the Dying in space made available by the city of Calcutta (Kolkata). With the help of Indian officials she converted anabandoned Hindu temple into the Kalighat Home for the Dying, a free hospice for the poor. She renamed it Kalighat, the Home of the Pure Heart (NirmalHriday).[32] Those brought to the home received medical attention and were afforded the opportunity to die with dignity, according to the rituals of their faith; Muslims were read the Quran, Hindus received water from the Ganges, and Catholics received the Last Rites.[33] "A beautiful death," she said, "is for people who lived like animals to die like angels—loved and wanted."[33]Mother Teresa soon opened a home for those suffering from Hansen's disease, commonly known as leprosy, and called the hospice Shanti Nagar (City of Peace).[34] The Missionaries of Charity also established several leprosy outreach clinics throughout Calcutta, providing medication, bandages and food.[35]As the Missionaries of Charity took in increasing numbers of lost children, Mother Teresa felt the need to create a home for them. In 1955 she opened the NirmalaShishuBhavan, the Children's Home of the Immaculate Heart, as a haven for orphans and homeless youth.[36]The congregation soon began to attract both recruits and charitable donations, and by the 1960s had opened hospices, orphanages and leper houses all over India. Mother Teresa then expanded the order throughout the globe. Its first house outside India opened in Venezuela in 1965 with five sisters.[37] Others followed in Rome, Tanzania, and Austria in 1968; during the 1970s the order opened houses and foundations in dozens of countries in Asia, Africa, Europe and the United States.[38]The Missionaries of Charity Brothers was founded in 1963, and a contemplative branch of the Sisters followed in 1976. Lay Catholics and non-Catholics were enrolled in the Co-Workers of Mother Teresa, the Sick and Suffering Co-Workers, and the Lay Missionaries of Charity. In answer to the requests of many priests, in 1981 Mother Teresa also began the Corpus Christi Movement for Priests,[39] and in 1984 founded with Fr. Joseph Langford the Missionaries of Charity Fathers[40] to combine the vocational aims of the Missionaries of Charity with the resources of the ministerial priesthood. By 2007 the Missionaries of Charity numbered approximately 450 brothers and 5,000 sisters worldwide, operating 600 missions, schools and shelters in 120 countries.[41]。
pheic名词解释
PHEIC是指国际关注的突发公共卫生事件,也叫做国际关注的公共卫生紧急事件,它是世界卫生组织也就是WHO发布的一项正式声明。
通俗的讲就是当一种疾病的传播超出了发生该疫情的地区,并对该地区的公共卫生造成重大的影响,并且可能会对其他地区的公共卫生造成同样严重的风险,这时世界卫生组织就会将该疾病列为国际关注的突发公共卫生事件也就是PHEIC。
PHEIC不针对具体的国家,而是一种全球性的协调机制。
PHEIC 是世卫组织传染病应急机制中的最高等级。
PHEIC的定义是通过疾病的国际传播构成对其他国家的公共卫生风险,以及可能需要采取协调一致的国际应对措施的不同寻常事件。
请注意,PHEIC的宣布和解除是由世界卫生组织总干事根据世卫组织专家委员会的建议做出的。
在PHEIC宣布生效后,世卫组织会定期评估疫情状况,并决定是否需要更新或延长PHEIC状态。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
Epidemics control and logistics operations:A reviewThomas K.Dasaklis n,Costas P.Pappis,Nikolaos P.RachaniotisUniversity of Piraeus,Department of Industrial Management and Technology,80Karaoli&Dimitriou Str.,18534Piraeus,Greecea r t i c l e i n f oArticle history:Received15September2010Accepted17May2012Available online28May2012Keywords:Epidemics controlEmergency supply chainsEpidemics control logisticsa b s t r a c tOutbreaks of epidemics account for a great number of municable or infectious diseases arealso a major cause of mortality in the aftermath of natural or man-made disasters.Effective control ofan epidemic outbreak calls for a rapid response.Available resources such as essential medical suppliesand well-trained personnel need to be deployed rapidly and to be managed in conjunction withavailable information andfinancial resources in order to contain the epidemic before it reachesuncontrollable or disastrous proportions.Therefore,the establishment and management of anemergency supply chain during the containment effort are of paramount importance.This paperfocuses on defining the role of logistics operations and their management that may assist the control ofepidemic outbreaks,critically reviewing existing literature and pinpointing gaps.Through the analysisof the selected literature a series of insights are derived and several future research directions areproposed.In conclusion,this paper provides both academics and practitioners with an overview ofliterature on epidemics control and logistics operations aiming at stimulating further interest in thearea of epidemics control supply chain management.&2012Elsevier B.V.All rights reserved.1.IntroductionAmong disasters,outbreaks of epidemics account for excessivedamages of human and material capital,including a great number ofdeaths.Polio,smallpox,cholera and HIV are among the diseases thatcontinue to pose a threat for many developing and developedcountries.Human history is full of public health incidents wherepandemics occurred in a certain period of time causing suffering anddeath.For example,plague epidemics in late Medieval Europecharacterized by high mortality rates caused many fatalities,whilethe1918–1919Spanish influenza pandemic killed an estimated20to50million people worldwide(Benedictow,1987;Tumpey et al.,2005).Epidemic outbreaks may occur in the context of naturalcauses such as the recent outbreak of novel influenza A(H1N1)viruswhere,according to the World Health Organization(WHO),from thestart of the pandemic until May28,2010,the virus had alreadyspread over214countries causing18,114deaths(http://www.who.int/csr/don/2010_05_28/en/index.html).Epidemic outbreaks arealso very common in the aftermath of natural disasters.Acuterespiratory infections,measles,malaria and diarrhea are the mostprevalent infectious diseases after natural disasters and all of themare closely related to unsanitary health conditions and malnutritionof the population affected(Watson et al.,2007).Finally,deliberatebioterrorist actions and the release of biological warfare agentscould also lead to epidemic outbreaks.According to Henderson(1999)smallpox and anthrax are considered to be among the twomost feared biological agents that could be used in a probablebioterrorist attack‘‘as they have the potential to be grown reason-ably easily and in large quantities and are sturdy organisms that areresistant to destruction’’.The anthrax attacks of2001in the UnitedStates demonstrated the threat of a possible bioterrorist action andits severe impacts.The importance of addressing epidemic outbreaks nowadays iseven greater as the general framework in which they may occurhas dramatically changed during the last years.New challengeshave arisen and certain drivers like climate change,populationdensity and urbanization could serve as catalysts for the accel-eration of pandemic incidents.Climate change is expected to playa crucial role in the birth and transmission of specific diseases(McMichael,2003).Many studies suggest that diseases such asyellow fever,dengue and cholera are re-emerging due to climatechange among other factors(Shope,1991).Specific arbovirusdiseases have recently emerged outside their usual endemicrange and this could be attributed to changes in climate patterns(Gould and Higgs,2009).Apart from climate change,the wit-nessed rapid urbanization of the world’s population along with asubstantial growth in general population could lead to acceler-ated epidemic outbreaks,rendering socioeconomic systems evenmore vulnerable.A possible outbreak combined with changes indemographic conditions like population distribution,size anddensity could potentially lead to a pandemic of unprecedentedContents lists available at SciVerse ScienceDirectjournal homepage:/locate/ijpeInt.J.Production Economics0925-5273/$-see front matter&2012Elsevier B.V.All rights reserved./10.1016/j.ijpe.2012.05.023n Corresponding author.Tel.:þ302104142150;fax:þ302104142629.E-mail addresses:dasaklis@unipi.gr(T.K.Dasaklis),pappis@unipi.gr(C.P.Pappis),nraxan@unipi.gr(N.P.Rachaniotis).Int.J.Production Economics139(2012)393–410proportion where available capacities and resources could be strained to their limits.The control of an epidemic’s outbreak calls for a prompt response.Certain control protocols should be followed and huge amounts of supplies together with the necessary human resources(medical and other personnel)should be available in order to be utilized during the containment effort.For example,if a smallpox attack happens,vaccination of the affected population should take place within4days while in the case of an anthrax outbreak the distribution of antibiotics should take place within2 days of the event(Lee,2008).As a consequence,any control of an epidemic’s outbreak should rely on the establishment of an emergency supply chain as a plethora of logistics issues is raised according to the control strategy adopted and the very nature of the agent triggering the outbreak.All the logistics operations such as transportation of medical supplies and commodities or the deployment of medical personnel must be managed in conjunc-tion with available information andfinancial resources in order to contain the epidemic before it reaches critical proportions.This is the reason why leading international health organizations like World Health Organization and the Pan American Health Organi-zation explicitly recognize the importance of logistics operations to any successful health task undertaken for the control of an outbreak.A basic component of the World Health Organization’s Epidemic and Pandemic Alert and Response program addresses logistic issues in order‘‘to provide operational assistance in the ongoing management of logistics required for epidemic and pandemic preparedness and response and for the rapid deployment of medical and laboratory supplies,transport,communications as well as the rapid deployment of outbreak response teams’’(http://www.afro. who.int/en/divisions-a-programmes/ddc/epidemic-a-pandemic-a lert-and-response/programme-components/logistics.html).Inter-national aid organizations,like the United States Agency for International Development(USAID),also pay attention to logis-tical issues in the case of epidemic outbreaks control.The USAID9DELIVER PROJECT,Task Order2-Supply Chain Manage-ment for Outbreak Response supports USAID’s efforts to mitigate existing and emerging pandemic threats by procuring,stock-piling,and distributing outbreak response commodities(http:// /dhome/topics/health/outbreakresponse).Although logistics operations are very important for control-ling an epidemic’s outbreak,the scientific community has yet to produce a large amount of well-established approaches that explicitly incorporate epidemics logistics features.Even further, issues of appropriately managing epidemics logistics operations have been paid limited attention.So far,epidemics logistics operations have been seen through the lens of resource allocation or have been implicitly incorporated as qualitative variables into preparedness and response plans.For example,a considerable volume of scientific research has been conducted in the case of resources allocation for the control of infectious diseases (Brandeau,2005;Rachaniotis et al.,2012;Zaric and Brandeau, 2001,2002)or in the case of developing preparedness and response plans for health-care facilities to deal with epidemic outbreaks(Ammon et al.,2007;Ippolito et al.,2006;Rebmann et al.,2007;Savoia et al.,2009;Webby and Webster,2003).While resource allocation models and contingency plans provide a strong insight towards epidemics control,they often overlook some critical aspects:allocation of resources cannot be accom-plished unless the availability of these resources is assured at the right time,right place and right quantity.In addition,contingency plans often overlook critical logistical parameters like patient flow logistics and the availability of workforce and,therefore, several decision variables related to possible bottlenecks or workforce shortages are omitted.Results of many full-scale exercises have shown that logistics poses a real challenge when controlling an epidemic outbreak(Aaby et al.,2006).Logistical barriers could also be apparent even when establishing a simple quarantine program in terms of transferring supplies across quarantine lines,recruiting qualified medical personnel etc. (Barbera et al.,2001).The aforementioned gap in the literature concerning epidemics logistics operations and their management has been our main driver for conducting this review paper.Our scope is to shed light into the general context of emergency supply chain management in the case of epidemics containment.Thus the objectives of the paper may be summarized as follows:To define and inter-correlate the logistics operations taking place during the containment of an epidemic.Tofind to what extent literature has produced a critical mass of scientific work in terms of methodologies applied and research techniques utilized regarding the issues of epidemics control logistics.To determine whether the methodologies applied in business logistics problems could be utilized in the context of epidemics control logistics(e.g.Operational Research methods utilization etc.).To develop a more robust definition of the epidemics control supply chain and enhance its understanding.To look for trends in epidemics control supply chain manage-ment academic research and to propose areas for further investigation.The remainder of the paper is structured as follows:in Section2 some key concepts of emergency and humanitarian supply chain management are outlined.Section3provides an overview of the research methodology utilized for the purposes of the review and the boundaries of our research.In Section4an inventory of the logistics operations taking place during the control of an epidemic is developed.Section5deals with the analysis and classification of the selected literature regarding epidemics logistics operations.In Section6the mainfindings of the review are discussed.Finally,the paper ends with some concluding remarks and suggestions for future research directions.2.Epidemics control and emergency supply chain managementThe control of infectious diseases may be based on measures adopted at international,national,provincial or even community level.Reducing the rate by which susceptibles become infected, reducing the mortality rate for those already infected and increas-ing the immunization capacity of the population comprise the main objectives of any containment effort.Such control measures demand the launching of vaccination or quarantine programs over certain geographic regions.They also call for interventions that will ensure the provision of medical supplies like antiretro-viral drugs,antibiotics,clean water/adequate sanitation and better nutrition conditions in order that the multiplication of the infectious agent be reduced.Control measures could be adopted with the aim either to prevent the spread after the initiation of an infectious disease(as pre-event measures)or to control a confirmed outbreak(post-event measures).In thefirst case,a certain level of medical supplies should be kept in order to be utilized immediately at the initiation of an epidemic.In the second case the deployment of all the available resources should rapidly take place providing either treatment to those already infected or prophylaxis to those susceptible to the agent triggering the outbreak.T.K.Dasaklis et al./Int.J.Production Economics139(2012)393–410 394It is therefore evident that the control of any epidemic out-break should be based on the establishment of an emergency supply chain as physical movement of large amounts of medical supplies takes place.For example,manufacturers should produce vaccines,antiretroviral drugs and complementary medical ernments and public health institutions should pur-chase and stockpile well in advance a plethora of such supplies for a possible outbreak.During the containment effort transportation and distribution of these supplies from central warehouses to regional store sites and then to local Points of Dispensing(POD) will have to take place.In the case of vaccines,a cold supply chain must be established to assure that vaccines are transported, stored and packed in accordance with manufacturers’instructions (stable temperature).Affected people will proceed to treatment centers where patientflow operations along with dispensing activities of the medical supplies should be managed appropri-ately.Reverse logistics activities should also take place as dan-gerous wastes must be treated carefully or disposed of in such a way that they do not pose a threat for the medical personnel and people engaged in the containment effort.In addition,coordina-tion issues across the entire emergency supply chain arise. Manufacturers,governments,primary health care institutes and possibly military agencies are few among many players that should be coordinated during the control effort.Finally,managing the information regarding the demand for medical supplies as well as theflow of funds is also critical.In Fig.1an End-to-End approach of the epidemics control supply chain is depicted.Note that the reverseflow may refer to only a part of the medical supplies.The outbreak of an epidemic can be related to a high rate of mortality,thus it may be characterized as a disaster.Disaster Operations in general are a set of activities that are performed before,during and after a disaster with the goal of preventing loss of human life,reducing its impact on the economy and returning to a state of normalcy(Altay and Green Iii,2006).Disaster management is‘‘an applied science which seeks,by the systematic observation and analysis of disasters,to improve measures relating to prevention,mitigation,preparedness,emergency response and recov-ery’’(Pettit and Beresford,2005).Recent studies have demonstrated the contribution of appro-priate management of disasters to save or offer relief to as many people as possible.According to Kovacs and Spens(2007)an emergency or humanitarian supply chain encompasses a range of activities,including preparedness,planning,procurement,trans-port,warehousing,tracking and tracing and customs clearance. Humanitarian logistics is an umbrella term for a mixed array of operations,from disaster relief to continuous support for devel-oping regions,and could be defined as the process of planning, implementing and controlling the efficient,cost effectiveflow and storage of goods and materials as well as related information from the point of origin to the point of consumption for the purpose of alleviating the suffering of vulnerable people.As an example,one of the notable aspects of the relief effort following the2004Asian tsunami was the public acknowledgment of the role of logistics in effective relief(Thomas and Kopczak,2007).The management of emergency and/or humanitarian supply chains has recently attracted the attention of both practitioners and researchers.Such supply chains have much in common with commercial supply chains but at the same time they pose significant challenges as they operate under uncertain,and many times,chaotic conditions.Research methodologies widely utilized in solving business logistics problems could be adopted in the context of emergency supply chain operations.Similarities exist-ing between commercial and emergency supply chains offer the opportunity of transferring knowledge from the business sector to humanitarian organizations(Maon et al.,2009).Even at a long-term level,strategies adopted in commercial supply chains could be also adopted in the case of emergency and/or humanitarian supply chains in an effort to match supply with demand (Oloruntoba and Gray,2006;Taylor and Pettit,2009).A very comprehensive description towards the issues of humanitarian logistics can be found in Van Wassenhove(2006).Research conducted so far towards emergency and/or huma-nitarian supply chain operations has been targeted towards inventory management,facility location,transportation problems and performance measurement.For example,Beamon and Kotleba(2006)and Clay Whybark(2007)examined the problem of inventory management in case of response to emergencies. Balcik and Beamon(2008)examined the facility location problem of a humanitarian relief chain responding to quick-onset disas-ters.Balcik et al.(2008)studied the‘‘last mile’’distribution problem of the relief chain,which refers to the distribution of emergency supplies from local distribution centers tofinal ben-eficiaries affected by disasters.Issues of performance measure-ment in humanitarian supply chains are examined in Beamon and Balcik(2008)and Van Der Laan et al.(2009).Finally,coordination and knowledge sharing issues or even the role of all the players taking part in an emergency and/or humanitarian supply chain have also been the subject of research(Balcik et al.,2010;Kova´cs and Spens,2010;Pettit and Beresford,2005).3.Research methodology and boundariesThe literature regarding epidemics containment is vast.Three basic streams of research conducted so far may be identified.The first stream consists of research addressing pharmaceutical inter-ventions for the control of an epidemic.In this case,public health treatment programs(like vaccination campaigns)take place where limited resources are utilized.These resources couldbe Fig.1.Materialsflow of the epidemics control supply chain(End-to-End approach).T.K.Dasaklis et al./Int.J.Production Economics139(2012)393–410395either discrete(like vaccines,antibiotics or antiretroviral drugs, etc.)or continuous(like funds).The second stream consists of research approaches addressing non-pharmaceutical interven-tions like the closure of schools,voluntary quarantines over a wide area,social distancing and travel limitations.Finally,the third stream consists of research approaches where the pharma-ceutical and non-pharmaceutical interventions are combined and harmonized control actions are proposed.From the aforementioned literature our focus has been on pharmaceutical and harmonized approaches where certain logis-tics operations features are incorporated into the decision making process(either quantitative or qualitative).Therefore,this review covers the logistical aspects that support the pre-event as well as post-event logistics operations in the case of emergencies like an unprecedented pandemic outbreak,a bioterrorist attack,epi-demic outbreaks during mass gatherings or epidemic outbreaks in the aftermath of natural or man-made disasters.As a conse-quence,this review does not take into consideration logistics aspects arising in the context of seasonal influenza outbreaks or relevant diseases’outbreaks which may be expected,anticipated or last for a long period of time(like HIV outbreaks).It is worth mentioning that this review focuses on the opera-tional issues arising in relation to the control of epidemics.Thus papers addressing problems such as resource allocation or general contingency plans have not been included in the main reference list.For the interested reader an additional reference list can be found after the main reference list,where several resource allocation papers as well as contingency plan papers are cited. Furthermore,modeling approaches not calibrated to the epi-demics control context have not been included in the classifica-tion framework of this review.A relevant survey regarding modeling approaches in the generic context of emergency supply chain management can be found in Caunhye et al.(2012).Apart from the aforementioned limitations,in this review two exemp-tions have been made regarding the papers of Chick et al.(2008) and Ak et al.(in press).The justification of these exemptions is provided in the relevant section where both papers are cited. Finally,this review cannot by any means be considered as an exhaustive one.In order to review the available literature ourfirst task was to define our sources and to establish the appropriate search criteria. Epidemics control handbooks and relevant information from several databases(governmental and international agencies such as the World Health Organization,the Pan-American Health Organization and the European Centre for Disease Prevention and Control etc.)were studied in order to determine the logistics operations taking place during the control of an outbreak.Key-word searches were made through several scientific databases including Springer,Science Direct and Scopus.During the selec-tion process all abstracts or list of references from the papers were examined in order to locate additional relevant research works.A total number of73papers werefinally selected.We are aware of at least one review regarding OR/MS research in disaster operations management(Altay and Green Iii,2006),in which epidemics control issues were excluded and one review regarding bioterrorism response logistics(Bravata et al.,2004a). In addition,Brandeau et al.(2009)made an inventory of health sector disaster response models in which logistical constraints were incorporated in the case of epidemic outbreaks,while Ferguson et al.(2003)reviewed the usage of available mathema-tical models when planning for smallpox outbreaks.The need for a more integrated incorporation of logistical constraints into existing modeling approaches was among thefindings of the review.For the classification of the selected literature all the logistical variables and relevant logistics aspects of each reference were initially identified.Our classification scheme was based on a three-level assessment framework presented in Fig.2.In thefirst level of assessment the various logistical features incorporated in each reference are classified according to the time framework in which they take place(pre-event or post-event).In the second level of assessment a context-specific classification is made where the logistics features are correlated to the nature of the epidemic’s outbreak.Finally,in the third level of assessment the logistical features and the methodologies applied(qualitative or quantita-tive)for solving the problem tackled are classified.It is worth mentioning that in the classification scheme the incorporated logistical features of each reference have been utilized as the main driver for the classification process.Such an approach not only provides the means for better synthesizing and analyzing the selected literature but also gives us the opportunity t o better understand the interdependencies between logistics operations and the general control context in which they take place.As a consequence,the classification scheme highlights several attri-butes of epidemics logistics operations and enables us to develop a more robust research agenda towards epidemics control supply chain management.4.Epidemics control and logistics operationsGovernmental agencies and health institutions should be prepared in advance for the control of epidemic outbreaks.This means that they should have in place robust contingency plans addressing issues like the availability of emergency medical stocks and well-trained personnel,their appropriate deployment, the availability of different types of vehicles for the transportation of essential medical supplies and commodities etc.Generally,it remains very difficult to define whether the needs for producing and distributing vaccines in the case of e.g.a possible pandemic influenza outbreak can be met(Fedson,2003;Webby and Webster,2003)by existing capacities.Consequently,any attempt to contain an epidemic outbreak demands real-time solutions that should ensure the effective management of all the logistics activities taking place,since sometimes these activities may become a real nightmare if not managed properly(Osterholm, 2001).In the sequence,an inventory of all the logistics operations taking place during the various phases of an epidemic’s contain-ment effort is provided.Generally,these phases could be classi-fied as follows(John Hopkins Bloomberg School of PublicHealth Fig.2.A framework for epidemics logistics literature classification.T.K.Dasaklis et al./Int.J.Production Economics139(2012)393–410 396and the International Federation of Red Cross and Red Crescent Societies,2008;World Health Organization,2005):PreparednessOutbreak investigationResponseEvaluation.4.1.PreparednessMany organizations around the world have established prepa-redness plans in the case of epidemic or pandemic outbreaks.Such plans range from community to national level and they include all the measures required for the successful containment of an out-break.The World Health Organization has published several pan-demic preparedness guidelines since1999and it updates them in the light of new developments regarding increased understanding of past pandemics,strengthened outbreak communications,greater insight on disease spread etc.(World Health Organization,2009).Epidemic preparedness aims at maintaining a certain level of available resources so as to reduce morbidity and mortality when an epidemic outbreak occurs.This means that pharmaceuticals and supplies should remain accessible or kept in large quantities (Richards et al.,1999)in order to assist a prompt response,if necessary.Procurement of vaccines and medical supplies and their exact storing location play a crucial role for the outcome of any containment effort.For instance,the Strategic National Stock-pile(SNS)program in the United States is an indicative prepared-ness program with the objective to maintain large quantities of medicine and medical supplies and to provide these materials to states and communities within twelve hours in the event of a large-scale public health emergency(Esbitt,2003).In addition,a certain amount of vaccines should be available for the immuniza-tion of control teams and health-care workers.This is of great importance as medical personnel will treat the veryfirst infected persons and should be protected against the disease that causes the outbreak.Among the most important logistics operations taking place and relevant logistics-oriented decisions to be made during the phase of preparedness are the following(John Hopkins Bloomberg School of Public Health and the International Federation of Red Cross and Red Crescent Societies,2008;World Health Organization,2005,2008):Identification of sources for the procurement of medical supplies and relevant commoditiesContract management for all the materials procuredInventory management for all the essential medical supplies (vaccines,antibiotics,antiretroviral drugs)and supplementary medical commodities(personal protective supplies)keptPeriodical review and updating of medical suppliesFacility location and capacity determination for stockpiling centersNetwork design for transportation/distribution activities and selection of appropriate means for transportation/distribution activitiesSelection of appropriate vaccination facilities/health care sys-tems and their capacity(size,availability of rooms and designated areas,availability and scheduling of personnel etc.) Availability of funds.4.2.Outbreak investigationOutbreak investigation consists of the detection of any sus-pected outbreak and its confirmation through laboratory testing.In order to detect and confirm a suspected outbreak,surveillance systems must be put in place in order to provide the decision makers of the health agencies in charge with the essential information regarding any unexplained infection increases seen over a period of time through the systematic analysis of data collected.Surveillance systems provide adequate information that facilitates the development of an initial response framework where the type and magnitude of the containment effort could be determined once epidemic thresholds have been reached.The term epidemic threshold refers to the level of disease above which an urgent response is required.It is specific for each disease and depends on the infectiousness,other determinants of transmission and local endemicity levels(World Health Organization,2005).Leading world health organizations have developed surveillance systems covering cases like pandemic outbreaks(European Centre for Disease Prevention and Control,June,2009),epidemic out-breaks following natural disasters(World Health Organization, 2005)or even possible disease outbreaks during mass gatherings (World Health Organization,2008).Additionally,surveillance sys-tems have been developed by the scientific community(Dato et al., 2004;Krause et al.,2007;Lombardo et al.,2003)and many researchers have studied relevant issues arising during the detec-tion and confirmation of diseases outbreaks attributed to bioter-rorist attacks(Bravata et al.,2004b;Buehler et al.,2003;Lober et al.,2002;Pavlin et al.,2003;Platt et al.,2003)or epidemic outbreaks related to specific agents(Arita et al.,2004;Dietz et al., 1990;Jansson et al.,2005).It is worth mentioning that the development of a surveillance system to detect epidemic outbreaks that occur during emergency situations(like a humanitarian crisis) may necessitate taking into consideration some context-specific features like the target population,the political context,the poor infrastructure and,finally,the presence of multiple partners in the field(M’ikanatha et al.,2007).Among the logistics activities that support the detection and confirmation mechanisms of a suspected outbreak are(U.S.Agency for International Development,2009; World Health Organization,2005):The provision of all the appropriate materials like report sheets to hospitals,emergency medical services and local public health departments that will be used for the collection of primary data regarding initial casesThe training of clinical workers to recognize unexpected patterns of the occurrence of specific diseases and to promptly identify and report suspected cases using standard definitions The provision of all the necessary commodities and resources to the outbreak response team that will facilitate and ensure its operational deploymentThe collection of specimens and their labelingThe secure transportation of specimens to the appropriate laboratory(using cold boxes and coolant blocks)The appropriate storage of specimens in the laboratory(kept within a specific temperature range)The procurement,handling,storing and distribution of labora-tory commodities,their classification,their quality assurance and quality control etc.It is clear that any successful attempt to contain an epidemic outbreak is closely related to the services provided by labora-tories.These services rely on a huge number of materials and commodities that laboratories utilize and they necessitate increased inventory management capabilities.Additionally,dur-ing epidemic outbreaks laboratories must ensure that they have the capacity to cope with increased testing demands(Crawford et al.,2010).A good reference regarding laboratory logistics can be found in U.S.Agency for International Development(2009).T.K.Dasaklis et al./Int.J.Production Economics139(2012)393–410397。